SCHEMBL19260288

SCHEMBL19260288

N#CN1CC=CC=CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28481306 0.65
SCHEMBL3634152 0.64
SCHEMBL16335091 0.63
SCHEMBL16335093 0.63
SCHEMBL1590186 0.59
SCHEMBL4777648 0.58 CHRM2 (0.30)
SCHEMBL7339263 0.57
SCHEMBL9853258 0.55
SCHEMBL2039363 0.55
Water SCHEMBL15388360 0.49

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3416969-A1 FUSED 1,4-OXAZEPINES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS The Regents of The University of Michigan (US) 2018-12-26 EP claimed
WO-2017142881-A1 FUSED 1,4-OXAZEPINES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-08-24 WO claimed
CN-115038707-A Azepine condensed ring compound and medical application thereof 中国医药研究开发中心有限公司 2022-09-09 CN disclosed